Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models. (science.org)

Authors: Lin HK … Rafiq S Journal: Science Translational Medicine Published: 2026-07-22 DOI: https://doi.org/10.1126/scitranslmed.adt9565